ArticleLeukemia2014
B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL).
Open access · hybridAbstract readLetter
In one paragraph
Article in Leukemia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 42 citations in OpenAlex.
- Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma.British journal of haematology · 2019Trial
- Identification and validation of BLK and OSBPL10 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma through machine learning algorithms.Scientific reports · 2026Article
- Non-receptor tyrosine kinase signaling pathways and therapeutic implications.Signal transduction and targeted therapy · 2026Review
- Schistosoma haematobium infection is associated with oncogenic gene expression in Cervical Mucosa, with enhanced effects following treatment: A pilot study.PLoS neglected tropical diseases · 2025Article
- Transcriptomic analysis identifies B-lymphocyte kinase as a therapeutic target for desmoplastic small round cell tumor cancer stem cell-like cells.Oncogenesis · 2024Article
- Desmoplastic small round cell tumor: from genomics to targets, potential paths to future therapeutics.Frontiers in cell and developmental biology · 2024Review
- The survival rate of laryngeal squamous cell carcinoma: impact of IL1RAP rs4624606, IL1RL1 rs1041973, IL-6 rs1800795, BLK rs13277113, and TIMP3 rs9621532 single nucleotide polymorphisms.Discover oncology · 2023Article
- Tyrosine kinases in nodal peripheral T-cell lymphomas.Frontiers in oncology · 2023Review
- Biological Effects of Human Exposure to Environmental Cadmium.Biomolecules · 2022Review
- Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma.Journal of pathology and translational medicine · 2022Article
- Genetic association and single-cell transcriptome analyses reveal distinct features connecting autoimmunity with cancers.iScience · 2022Article
- Reactivities of the Front Pocket N-Terminal Cap Cysteines in Human Kinases.Journal of medicinal chemistry · 2022Article
- Post-Translational Modifications of Proteins in Cytosolic Nucleic Acid Sensing Signaling Pathways.Frontiers in immunology · 2022Review
- Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension.International journal of molecular sciences · 2021Article
- A Random Walk-Based Method to Identify Candidate Genes Associated With Lymphoma.Frontiers in genetics · 2021Article
- Topical Application of Temperature-Sensitive Gel Containing Caerin 1.1 and 1.9 Peptides on TC-1 Tumour-Bearing Mice Induced High-Level Immune Response in the Tumour Microenvironment.Frontiers in oncology · 2021Article
- Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia.International journal of molecular sciences · 2020Review
- Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma.British journal of cancer · 2019Article
- Large-scale computational drug repositioning to find treatments for rare diseases.NPJ systems biology and applications · 2018Article
- Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma.Blood cancer journal · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 3 institutions in 2 countries.
D L PetersenDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
T KrejsgaardDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
J BerthelsenDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
S FredholmDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
A Willerslev-OlsenDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
N A SibbesenDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
C M BonefeldDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
M H AndersenCenter for Cancer Immune Therapy (CCIT), Department of Hematology, Herlev University Hospital, Herlev, Denmark.
C FrancavillaProteomics Program, NNF Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
J V OlsenProteomics Program, NNF Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
T HuLymphoma Diagnosis and Treatment Center, Department of Oncology, First Affiliated Hospital of Zhengzhou University, Henan, China.
M ZhangLymphoma Diagnosis and Treatment Center, Department of Oncology, First Affiliated Hospital of Zhengzhou University, Henan, China.
M A WasikDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
C GeislerDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
A WoetmannDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
N OdumDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
University of Copenhagen · DKHerlev Hospital · DKUniversity of Pennsylvania · US
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Gene Expression Regulation, NeoplasticAnimalsCell Line, TumorCell ProliferationDasatinibHumansLymphoma, T-Cell, CutaneousMiceNeoplasmsNeoplasm TransplantationPhosphorylationPyrimidinessrc-Family KinasesThiazolesBLK protein, humanDasatinibPyrimidinessrc-Family KinasesThiazoles
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.